Federal award (PURCHASE ORDER, fiscal year 2022)
Recipient: NOVOTECH DRUG DEVELOPMENT CONSULTING LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2020-06-25 to 2021-06-24
Current total value of award: $91000
Description: REGULATORY SUPPORT FOR FDA PRE-IND MEETING: QGRFT FOR THE PREVENTION OF SARS-COV-2 INFECTION